Tectorigenin ameliorates myocardial cell injury caused by hypoxia/reoxygenation by inhibiting autophagy via activation of PI3K/AKT/mTOR pathway.

MLA

Jijun Wu, et al. “Tectorigenin Ameliorates Myocardial Cell Injury Caused by Hypoxia/Reoxygenation by Inhibiting Autophagy via Activation of PI3K/AKT/MTOR Pathway.” Tropical Journal of Pharmaceutical Research, vol. 21, no. 8, Aug. 2022, pp. 1601–06. EBSCOhost, https://doi.org/10.4314/tjpr.v21i8.4.

APA

Jijun Wu, Yingli Zhou, Ming Guo, Jie Yang, Feifei Wu, & Jialin Wang. (2022). Tectorigenin ameliorates myocardial cell injury caused by hypoxia/reoxygenation by inhibiting autophagy via activation of PI3K/AKT/mTOR pathway. Tropical Journal of Pharmaceutical Research, 21(8), 1601–1606. https://doi.org/10.4314/tjpr.v21i8.4

Chicago

Jijun Wu, Yingli Zhou, Ming Guo, Jie Yang, Feifei Wu, and Jialin Wang. 2022. “Tectorigenin Ameliorates Myocardial Cell Injury Caused by Hypoxia/Reoxygenation by Inhibiting Autophagy via Activation of PI3K/AKT/MTOR Pathway.” Tropical Journal of Pharmaceutical Research 21 (8): 1601–6. doi:10.4314/tjpr.v21i8.4.